Filing Flows › Health Care › Longduoduo (LDDD)
Longduoduo (LDDD) earnings and revenue breakdown
Latest: Q4 FY26 · 10-K filed Sep 30, 2026 · Longduoduo (LDDD) Q4 FY26 earnings results →
Q4 FY26 Revenue down 33% year over year to $631K · 11¢ of every $1 of revenue lost · operating margin -11.4%
Longduoduo made $631K in Q4 FY26 (-33% Y/Y). Operating margin -11.4%, net loss $67K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-K filed Sep 30, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $631K in Q4 FY26, down 33% year over year and up 237% from the previous quarter.
Gross margin was 99.7%, up 0.8 points from Q4 FY25. Operating costs exceeded revenue by $72K, an operating margin of -11.4%. Operating expenses fell 12% while revenue fell 33%. The quarter ended with a net loss of $67K, narrower than the previous quarter's $190K loss. Minority interests bore $4K of it: to shareholders the quarter was a loss of $63K.
Operating cash flow was $275K (up 49% year over year). Non-cash charges added back $28K of depreciation. Working capital and other items added $313K. Capital expenditures of $0K left free cash flow of $274K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q4 FY26 | 10-K | Sep 30, 2026 | $631K | -33% | -11.4% | −$67K | $275K |
| Q3 FY26 | 10-Q | May 12, 2026 | $187K | -76% | -105.4% | −$190K | −$332K |
| Q2 FY26 | 10-Q | Feb 9, 2026 | $345K | -81% | -80.9% | −$274K | $269K |
| Q1 FY26 | 10-Q | Nov 12, 2025 | $659K | -14% | -12.8% | −$111K | −$374K |
| Q4 FY25 | 10-K | Sep 26, 2025 | $940K | -44% | 13.9% | $163K | $184K |
| Q3 FY25 | 10-Q | May 14, 2025 | $778K | -57% | -15.3% | −$116K | −$187K |
| Q2 FY25 | 10-Q | Feb 14, 2025 | $1.8M | -24% | 33.9% | $464K | $815K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Longduoduo
Longduoduo Company Limited (“Longduoduo”) was incorporated in the State of Nevada on October 25, 2021. Longduoduo’s principal corporate address is G3-5-8016, Shui’an Town, Ruyi Headquarters Base, Hohhot Economic Development District, Hohhot, Inner Mongolia, China, 010000. Our telephone number is +86 (0472) 510 4980. Our registered agent for service of process is Incorp Services, Inc., 3773 Howard Hughes Pkwy, Suite 500S, Las Vegas Nevada 89169-6014. Our website address is www.longduoduo.net. Our website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this report, and the inclusion of our website address in this report is an inactive textual reference only. You should not rely on any such information in making your decision whether to purchase our common stock.
In its own words, from its 10-K, filed Sep 30, 2026.
Longduoduo against its Services-Health Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -33% against the peers' median +13%. Operating margin: -11.4% against the peers' median 5.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LDDD Longduoduo | Q4 FY26 | $631K | -33% | -11.4% |
| PRVA Privia Health Group | Q3 2026 | $657M | +13% | 3.1% |
| LFST LifeStance Health Group | Q3 2026 | $456M | +25% | 7.3% |
| PIII P3 Health Partners | Q2 2026 | $386M | +9% | 10.7% |
| PNTG Pennant Group | Q3 2026 | $302M | +32% | 5.5% |
| INNV InnovAge Holding | Q1 FY27 | $265M | +12% | 7.6% |
| USPH U S Physical Therapy | Q3 2026 | $223M | +13% | 11.3% |
| WGS GeneDx Holdings | Q2 2026 | $114M | +11% | -15.3% |
| OMDA Omada Health | Q3 2026 | $91.3M | +34% | 5.3% |
Source: Longduoduo 10-K on SEC EDGAR · CIK 1892316 · Services-Health Services
More on LDDD
History
Every quarter: Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results